Select Clinical Trial
EAY131: Molecular Analysis for Therapy Choice (NCI-MATCH)
- Men or women aged 18 or older diagnosed with solid tumor cancers or lymphomas that have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. For more information, contact the Clinical Trials Office at 910-715-2200.
ROBUST: Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma
- Men or women, ages 18 and older, newly diagnosed with diffuse large B-Cell Lymphoma. For additional criteria, call our Clinical Trials office at (910) 715-2200.